May 22, 2024

Point-of-care Biosensors Market Size Analysis 2023 To 2032

The global point-of-care biosensors market size accounted for US$ 71.24 Bn in 2022 and is projected to reach around USD 159.01 Bn by 2032, growing at a CAGR of 8.36% from 2023 to 2032.

Point-of-care Biosensors Market Size 2023 To 2032

Report Summary

The global point-of-care biosensors market report provides a Point-by-Point and In-Depth analysis of global market size, regional and country-level market size, market share, segmentation market growth, competitive landscape, sales analysis, opportunities analysis, strategic market growth analysis, the impact of domestic and global market key players, value chain optimization, trade regulations, recent developments, product launches, area marketplace expanding, and technological innovations.

The study offers a comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales in the point-of-care biosensors market across the globe.

A comprehensive estimate on the point-of-care biosensors market has been provided through an optimistic scenario as well as a conservative scenario, taking into account the sales of point-of-care biosensors during the forecast period. Price point comparison by region with global average price is also considered in the study.

Download Access to a Free Copy of Our Latest Sample Report@ https://www.precedenceresearch.com/sample/2885

Point-of-care Biosensors Market Report Scope

Report CoverageDetails
Market Size in 2023USD 77.2 Billion
Market Size by 2032USD 159.01 Billion
Growth Rate from 2023 to 2032CAGR of 8.36%
Largest MarketNorth America
Fastest Growing MarketAsia Pacific
Base Year2022
Forecast Period2023 to 2032
Segments CoveredBy Product, By Platforms, By Purchase, By Sample, and By End User
Regions CoveredNorth America, Europe, Asia-Pacific, Latin America and Middle East & Africa

Key Highlights:

Reports Coverage: It incorporates key market sections, key makers secured, the extent of items offered in the years considered, worldwide containerized point-of-care biosensors market and study goals. Moreover, it contacts the division study gave in the report based on the sort of item and applications.

Market Outline: This area stresses the key investigations, market development rate, serious scene, market drivers, patterns, and issues notwithstanding the naturally visible pointers.

Market Production by Region: The report conveys information identified with import and fare, income, creation, and key players of every single local market contemplated are canvassed right now.

Also Read: Military Drones Market Size To Cross USD 28.84 Bn By 2032

Point-of-care Biosensors Market Players

The report includes the profiles of key point-of-care biosensors market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information, key development in past five years.

Major companies operating in this area

  • Abaxis
  • Abbott Laboratories
  • Accubiotech Co, Ltd.
  • ACON Laboratories, Inc
  • Becton, Dickinson and Company
  • Biolytical Laboratories
  • Danaher Corporation (HemoCue)
  • Siemens Healthineers
  • Meridian Bioscience, Inc

Market Segmentation

By Product

  • Glucose Monitoring
  • HIV
  • Hepatitis C
  • Pregnancy

By Platforms

  • Microfluidics
  • Dipsticks
  • Immunoassays

By Purchase

  • OTC
  • Prescription

By Sample

  • Blood
  • Urine

By End User

  • Pharmacy
  • Hospital
  • Homecare

Regional Segmentation

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
  • Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
  • Latin America (Brazil and Rest of Latin America)
  • Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)

Research Methodology

Secondary Research

It involves company databases such as Hoover’s: This assists us to recognize financial information, the structure of the market participants and industry’s competitive landscape.

The secondary research sources referred in the process are as follows:

  • Governmental bodies, and organizations creating economic policies
  • National and international social welfare institutions
  • Company websites, financial reports and SEC filings, broker and investor reports
  • Related patent and regulatory databases
  • Statistical databases and market reports
  • Corporate Presentations, news, press release, and specification sheet of Manufacturers

Primary Research

Primary research includes face-to-face interviews, online surveys, and telephonic interviews.

  • Means of primary research: Email interactions, telephonic discussions and Questionnaire-based research etc.
  • In order to validate our research findings and analysis, we conduct primary interviews of key industry participants. Insights from primary respondents help in validating the secondary research findings. It also develops Research Team’s expertise and market understanding.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Point-of-care Biosensors Market 

5.1. COVID-19 Landscape: Point-of-care Biosensors Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Point-of-care Biosensors Market, By Product

8.1. Point-of-care Biosensors Market Revenue and Volume, by Product, 2023-2032

8.1.1. Glucose Monitoring

8.1.1.1. Market Revenue and Volume Forecast (2020-2032)

8.1.2. HIV

8.1.2.1. Market Revenue and Volume Forecast (2020-2032)

8.1.3. Hepatitis C

8.1.3.1. Market Revenue and Volume Forecast (2020-2032)

8.1.4. Pregnancy

8.1.4.1. Market Revenue and Volume Forecast (2020-2032)

Chapter 9. Global Point-of-care Biosensors Market, By Platforms

9.1. Point-of-care Biosensors Market Revenue and Volume, by Platforms, 2023-2032

9.1.1. Microfluidics

9.1.1.1. Market Revenue and Volume Forecast (2020-2032)

9.1.2. Dipsticks

9.1.2.1. Market Revenue and Volume Forecast (2020-2032)

9.1.3. Immunoassays

9.1.3.1. Market Revenue and Volume Forecast (2020-2032)

Chapter 10. Global Point-of-care Biosensors Market, By Purchase 

10.1. Point-of-care Biosensors Market Revenue and Volume, by Purchase, 2023-2032

10.1.1. OTC

10.1.1.1. Market Revenue and Volume Forecast (2020-2032)

10.1.2. Prescription

10.1.2.1. Market Revenue and Volume Forecast (2020-2032)

Chapter 11. Global Point-of-care Biosensors Market, By Sample

11.1. Point-of-care Biosensors Market Revenue and Volume, by Sample, 2023-2032

11.1.1. Blood

11.1.1.1. Market Revenue and Volume Forecast (2020-2032)

11.1.2. Urine

11.1.2.1. Market Revenue and Volume Forecast (2020-2032)

Chapter 12. Global Point-of-care Biosensors Market, By End User

12.1. Point-of-care Biosensors Market Revenue and Volume, by End User, 2023-2032

12.1.1. Pharmacy

12.1.1.1. Market Revenue and Volume Forecast (2020-2032)

12.1.2. Hospital

12.1.2.1. Market Revenue and Volume Forecast (2020-2032)

12.1.3. Homecare

12.1.3.1. Market Revenue and Volume Forecast (2020-2032)

Chapter 13. Global Point-of-care Biosensors Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Volume Forecast, by Product (2020-2032)

13.1.2. Market Revenue and Volume Forecast, by Platforms (2020-2032)

13.1.3. Market Revenue and Volume Forecast, by Purchase (2020-2032)

13.1.4. Market Revenue and Volume Forecast, by Sample (2020-2032)

13.1.5. Market Revenue and Volume Forecast, by End User (2020-2032)

13.1.6. U.S.

13.1.6.1. Market Revenue and Volume Forecast, by Product (2020-2032)

13.1.6.2. Market Revenue and Volume Forecast, by Platforms (2020-2032)

13.1.6.3. Market Revenue and Volume Forecast, by Purchase (2020-2032)

13.1.6.4. Market Revenue and Volume Forecast, by Sample (2020-2032)

13.1.6.5. Market Revenue and Volume Forecast, by End User (2020-2032)

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Volume Forecast, by Product (2020-2032)

13.1.7.2. Market Revenue and Volume Forecast, by Platforms (2020-2032)

13.1.7.3. Market Revenue and Volume Forecast, by Purchase (2020-2032)

13.1.7.4. Market Revenue and Volume Forecast, by Sample (2020-2032)

13.1.7.5. Market Revenue and Volume Forecast, by End User (2020-2032)

13.2. Europe

13.2.1. Market Revenue and Volume Forecast, by Product (2020-2032)

13.2.2. Market Revenue and Volume Forecast, by Platforms (2020-2032)

13.2.3. Market Revenue and Volume Forecast, by Purchase (2020-2032)

13.2.4. Market Revenue and Volume Forecast, by Sample (2020-2032)

13.2.5. Market Revenue and Volume Forecast, by End User (2020-2032)

13.2.6. UK

13.2.6.1. Market Revenue and Volume Forecast, by Product (2020-2032)

13.2.6.2. Market Revenue and Volume Forecast, by Platforms (2020-2032)

13.2.6.3. Market Revenue and Volume Forecast, by Purchase (2020-2032)

13.2.7. Market Revenue and Volume Forecast, by Sample (2020-2032)

13.2.8. Market Revenue and Volume Forecast, by End User (2020-2032)

13.2.9. Germany

13.2.9.1. Market Revenue and Volume Forecast, by Product (2020-2032)

13.2.9.2. Market Revenue and Volume Forecast, by Platforms (2020-2032)

13.2.9.3. Market Revenue and Volume Forecast, by Purchase (2020-2032)

13.2.10. Market Revenue and Volume Forecast, by Sample (2020-2032)

13.2.11. Market Revenue and Volume Forecast, by End User (2020-2032)

13.2.12. France

13.2.12.1. Market Revenue and Volume Forecast, by Product (2020-2032)

13.2.12.2. Market Revenue and Volume Forecast, by Platforms (2020-2032)

13.2.12.3. Market Revenue and Volume Forecast, by Purchase (2020-2032)

13.2.12.4. Market Revenue and Volume Forecast, by Sample (2020-2032)

13.2.13. Market Revenue and Volume Forecast, by End User (2020-2032)

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Volume Forecast, by Product (2020-2032)

13.2.14.2. Market Revenue and Volume Forecast, by Platforms (2020-2032)

13.2.14.3. Market Revenue and Volume Forecast, by Purchase (2020-2032)

13.2.14.4. Market Revenue and Volume Forecast, by Sample (2020-2032)

13.2.15. Market Revenue and Volume Forecast, by End User (2020-2032)

13.3. APAC

13.3.1. Market Revenue and Volume Forecast, by Product (2020-2032)

13.3.2. Market Revenue and Volume Forecast, by Platforms (2020-2032)

13.3.3. Market Revenue and Volume Forecast, by Purchase (2020-2032)

13.3.4. Market Revenue and Volume Forecast, by Sample (2020-2032)

13.3.5. Market Revenue and Volume Forecast, by End User (2020-2032)

13.3.6. India

13.3.6.1. Market Revenue and Volume Forecast, by Product (2020-2032)

13.3.6.2. Market Revenue and Volume Forecast, by Platforms (2020-2032)

13.3.6.3. Market Revenue and Volume Forecast, by Purchase (2020-2032)

13.3.6.4. Market Revenue and Volume Forecast, by Sample (2020-2032)

13.3.7. Market Revenue and Volume Forecast, by End User (2020-2032)

13.3.8. China

13.3.8.1. Market Revenue and Volume Forecast, by Product (2020-2032)

13.3.8.2. Market Revenue and Volume Forecast, by Platforms (2020-2032)

13.3.8.3. Market Revenue and Volume Forecast, by Purchase (2020-2032)

13.3.8.4. Market Revenue and Volume Forecast, by Sample (2020-2032)

13.3.9. Market Revenue and Volume Forecast, by End User (2020-2032)

13.3.10. Japan

13.3.10.1. Market Revenue and Volume Forecast, by Product (2020-2032)

13.3.10.2. Market Revenue and Volume Forecast, by Platforms (2020-2032)

13.3.10.3. Market Revenue and Volume Forecast, by Purchase (2020-2032)

13.3.10.4. Market Revenue and Volume Forecast, by Sample (2020-2032)

13.3.10.5. Market Revenue and Volume Forecast, by End User (2020-2032)

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Volume Forecast, by Product (2020-2032)

13.3.11.2. Market Revenue and Volume Forecast, by Platforms (2020-2032)

13.3.11.3. Market Revenue and Volume Forecast, by Purchase (2020-2032)

13.3.11.4. Market Revenue and Volume Forecast, by Sample (2020-2032)

13.3.11.5. Market Revenue and Volume Forecast, by End User (2020-2032)

13.4. MEA

13.4.1. Market Revenue and Volume Forecast, by Product (2020-2032)

13.4.2. Market Revenue and Volume Forecast, by Platforms (2020-2032)

13.4.3. Market Revenue and Volume Forecast, by Purchase (2020-2032)

13.4.4. Market Revenue and Volume Forecast, by Sample (2020-2032)

13.4.5. Market Revenue and Volume Forecast, by End User (2020-2032)

13.4.6. GCC

13.4.6.1. Market Revenue and Volume Forecast, by Product (2020-2032)

13.4.6.2. Market Revenue and Volume Forecast, by Platforms (2020-2032)

13.4.6.3. Market Revenue and Volume Forecast, by Purchase (2020-2032)

13.4.6.4. Market Revenue and Volume Forecast, by Sample (2020-2032)

13.4.7. Market Revenue and Volume Forecast, by End User (2020-2032)

13.4.8. North Africa

13.4.8.1. Market Revenue and Volume Forecast, by Product (2020-2032)

13.4.8.2. Market Revenue and Volume Forecast, by Platforms (2020-2032)

13.4.8.3. Market Revenue and Volume Forecast, by Purchase (2020-2032)

13.4.8.4. Market Revenue and Volume Forecast, by Sample (2020-2032)

13.4.9. Market Revenue and Volume Forecast, by End User (2020-2032)

13.4.10. South Africa

13.4.10.1. Market Revenue and Volume Forecast, by Product (2020-2032)

13.4.10.2. Market Revenue and Volume Forecast, by Platforms (2020-2032)

13.4.10.3. Market Revenue and Volume Forecast, by Purchase (2020-2032)

13.4.10.4. Market Revenue and Volume Forecast, by Sample (2020-2032)

13.4.10.5. Market Revenue and Volume Forecast, by End User (2020-2032)

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Volume Forecast, by Product (2020-2032)

13.4.11.2. Market Revenue and Volume Forecast, by Platforms (2020-2032)

13.4.11.3. Market Revenue and Volume Forecast, by Purchase (2020-2032)

13.4.11.4. Market Revenue and Volume Forecast, by Sample (2020-2032)

13.4.11.5. Market Revenue and Volume Forecast, by End User (2020-2032)

13.5. Latin America

13.5.1. Market Revenue and Volume Forecast, by Product (2020-2032)

13.5.2. Market Revenue and Volume Forecast, by Platforms (2020-2032)

13.5.3. Market Revenue and Volume Forecast, by Purchase (2020-2032)

13.5.4. Market Revenue and Volume Forecast, by Sample (2020-2032)

13.5.5. Market Revenue and Volume Forecast, by End User (2020-2032)

13.5.6. Brazil

13.5.6.1. Market Revenue and Volume Forecast, by Product (2020-2032)

13.5.6.2. Market Revenue and Volume Forecast, by Platforms (2020-2032)

13.5.6.3. Market Revenue and Volume Forecast, by Purchase (2020-2032)

13.5.6.4. Market Revenue and Volume Forecast, by Sample (2020-2032)

13.5.7. Market Revenue and Volume Forecast, by End User (2020-2032)

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Volume Forecast, by Product (2020-2032)

13.5.8.2. Market Revenue and Volume Forecast, by Platforms (2020-2032)

13.5.8.3. Market Revenue and Volume Forecast, by Purchase (2020-2032)

13.5.8.4. Market Revenue and Volume Forecast, by Sample (2020-2032)

13.5.8.5. Market Revenue and Volume Forecast, by End User (2020-2032)

Chapter 14. Company Profiles

14.1. Abaxis

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Abbott Laboratories

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Accubiotech Co, Ltd.

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. ACON Laboratories, Inc

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Becton, Dickinson and Company

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Biolytical Laboratories

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Danaher Corporation (HemoCue)

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Siemens Healthineers

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. Meridian Bioscience, Inc

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Emailsales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://www.pharma-geek.com